company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1051100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1051100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,748500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,748500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,302600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,159300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,178500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,124100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,109500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:27:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1055700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1055700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,752100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,752100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,303600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,206100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,97500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,FY,2009-01-01,2009-12-31,2012-03-01 14:36:02+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.62
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,258900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,258900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,261000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,261000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,182300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,182300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,276800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,276800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,198800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,198800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,14700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1104700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1104700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,786600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,786600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,318100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,227400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,74500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:58:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.66
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,827900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,827900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,587800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,587800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,137300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,155400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,59300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.78
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.78
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.78
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3YTD,2010-01-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.48
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,271400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,271400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,196700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,196700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,556500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,556500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,391100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,391100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,165400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,92400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2YTD,2010-01-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,281800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,281800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,198600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,198600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,274700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,274700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,192500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,192500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,210100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,210100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.09
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1192300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1192300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,853000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,853000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,339300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,191100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,229700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,109600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,92700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 15:10:33+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1173700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1173700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,841700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,841700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,332000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,193100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,243300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,88700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,62600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,896900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,896900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,642900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,642900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,254000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,142700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,82700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,293600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,293600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,212200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,212200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1151500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1151500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,826200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,826200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,325300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,192300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,237400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,603300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,603300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,430700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,430700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,172600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,97000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,116000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2YTD,2011-01-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,307900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,307900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,223300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,223300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1125400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1125400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,801500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,801500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,323900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,191700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,16200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,233300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.95
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.95
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.95
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,321500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,321500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,224000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,224000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1266400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1266400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,878700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,878700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,387700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,218100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,252600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,135100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,108600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.19
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 17:30:02+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1240300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1240300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,864800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,864800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,375500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,245000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,130500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,30800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,78500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,78500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,78500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,944900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,944900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,654700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,654700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,290200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,159400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,186600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,103600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,80200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,59600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,303800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,303800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1230100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1230100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,863600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,863600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,366500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,199800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,236200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,130300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,102700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.71
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,641100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,641100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,441300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,441300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,199800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,105700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,122500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,77300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,324800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,324800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1213200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1213200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,860800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,860800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,352400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,191800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,229900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,122500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,106200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,85100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,85100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,85100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.71
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,316300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,316300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,41700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1368400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1368400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,933700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,933700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,434700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,234900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,162400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,147100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,112300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,112300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 17:40:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,342700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,342700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1347200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1347200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,921600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,921600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,425600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,233600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,268600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,157000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,142000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,109800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,109800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1025700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1025700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,697600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,697600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,328100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,202600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,125500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,113600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,341800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,341800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1309200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1309200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,898700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,898700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,410500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,231200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,143600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,128700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,97800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,97800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,97800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,683900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,683900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,461300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,461300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,222600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,118800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,136800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,85800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,77900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,233600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,233600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1289500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1289500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,891200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,891200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,398300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,225900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,261600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,136700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,109900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,83200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,83200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,83200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,339400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,339400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,227700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,227700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1421400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1421400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,973600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,973600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,447800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,228700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,265800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,182000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,169000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,47200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,127100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,127100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,127100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.79
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.79
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 12:15:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,349800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,349800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1414300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1414300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,969600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,969600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,444700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,270400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,174300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,160900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,119300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,119300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,119300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.68
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.68
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.68
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,355900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,355900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,246000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,246000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1071600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1071600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,733500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,733500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,338100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,169900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,137400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,127400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,95700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,95700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,95700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1400200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1400200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,959900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,959900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,440300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,230000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,270300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,170000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,155300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,115100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,115100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,115100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,368900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,368900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,247100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,247100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,50400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,715700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,715700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,487500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,487500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,228200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,113900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,134800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,93400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1375800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1375800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,946400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,946400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,429400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,271000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,158400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,143700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,107700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,107700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,107700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,346800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,346800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1399800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1399800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,944000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,944000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,455800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,233000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,60100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,327200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,128600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,116100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,95600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,95600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,95600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.33
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.33
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,FY,2015-01-01,2015-12-31,2018-02-26 17:13:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,119600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,108300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1040100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1040100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,703900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,703900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,336200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,170600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,58100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,252800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,83400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,62200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1389900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1389900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,944000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,944000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,56600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,317900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,128000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,115100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,241500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,241500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,695600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,695600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,467700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,467700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,116000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,141000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,86900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,80200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1401300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1401300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,953800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,953800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,447500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,230800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,175500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,163100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,123100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,123100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,123100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.71
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1410500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1410500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,959400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,959400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,451100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,227500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,260600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,190500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,177400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,132900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,132900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,132900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1509100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1509100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1007700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1007700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,501400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,239600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,29800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,306200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,195200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,189800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.91
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,FY,2016-01-01,2016-12-31,2019-02-27 17:33:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,382300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,382300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,376700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,376700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,255600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,255600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1126800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1126800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,749100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,749100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,377700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,178900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,29100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,235200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,142500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,136600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,104400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,104400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,104400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1486500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1486500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,989200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,989200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,497300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,241300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,31100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,309600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,187700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,179200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,137800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,137800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,137800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.49
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,388000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,388000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,254700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,254700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,750100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,750100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,493500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,493500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,256600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,120600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,26600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,165400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,91200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,87300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1454300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1454300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,969800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,969800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,484500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,237600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,77300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,351600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,132900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,123200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,101700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,101700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,101700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,362100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,362100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,238800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,238800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,93300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1426000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1426000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,956600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,956600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,469400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,235900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,86700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,358600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,110800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,99800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,84800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,84800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,84800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1599100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1599100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1086200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1086200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,512900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,246000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,287100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,225800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,222400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,80900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,FY,2017-01-01,2017-12-31,2020-02-21 18:56:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.54
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,415600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,415600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,287000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,287000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,128600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,398200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,398200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,273100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,273100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1183500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1183500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,799200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,799200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,384300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,186400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,218900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,165400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,163100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.99
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1565800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1565800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1057800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1057800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,508000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,247100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,289900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,218100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,216300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,189900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,189900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,189900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,397600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,397600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,272600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,272600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,785300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,785300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,526100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,526100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,259200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,123800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,12600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,102500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.26
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1544300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1544300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1040300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1040300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,504000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,242800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,297500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,206500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,202700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,176500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,176500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,176500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.4
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.33
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.4
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,387700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,387700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,253500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,253500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1534700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1534700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1022400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1022400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,512300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,244000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,286600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,225700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,221500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,10600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,182400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,182400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,182400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.48
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.42
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.48
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1717400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1717400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1172000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1172000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,545400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,262900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,305100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,240300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,240700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,206900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.8
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.74
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.8
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,FY,2018-01-01,2018-12-31,2020-02-21 18:56:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,422500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,422500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,289300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,289300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,431700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,431700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,296100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,296100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1294900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1294900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,882700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,882700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,412200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,203200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,237700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,174500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,174900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1710500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1710500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1169700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1169700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,540800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,262800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,305900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,234900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,234200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,154900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.09
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.06
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.09
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,447500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,447500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,305300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,305300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,142200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,863200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,863200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,586600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,586600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,276600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,138300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,162900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,113700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,113800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,99700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1677000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1677000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1146700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1146700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,530300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,260500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-6400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,293300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,237000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,236000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,94300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,150700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.56
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,415700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,415700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,281300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,281300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1627100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1627100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1114000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1114000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,513100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,251800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,294400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,218700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,216600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,91200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,133400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,133400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,133400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,470600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,470600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,317400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,317400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,77400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1839900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1839900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1234200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1234200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,605700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,272700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,309100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,296600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,291800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,59000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,8900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,241700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,241700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,241700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.27
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,FY,2019-01-01,2019-12-31,2020-02-21 18:56:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.62
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1369300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1369300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,916800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,916800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,452500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,203700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,234000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,218500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,214400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,177800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,177800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,177800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.36
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.41
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1791800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1791800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1206100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1206100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,585700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,263400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,301400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,284300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,280200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,7000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,229800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,229800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,229800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.04
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,456100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,456100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,308300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,308300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,147800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,913200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,913200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,608500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,608500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,304700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,138900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,153500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,151200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,149500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,121500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,121500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,121500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1767400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1767400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1193900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1193900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,573500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,263500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-7100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,295700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,277800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,276400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,228700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,228700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,228700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,311800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,311800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,79600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,443500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,443500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,296700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,296700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1745200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1745200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1187400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1187400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,557800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,263200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,300200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,257600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,256900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,218700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,218700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,218700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.89
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.96
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1887900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1887900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1262000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1262000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,625900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,275900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,312000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,313900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,308400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,10100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,260600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,260600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,260600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.47
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,491500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,491500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,324500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,324500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,167000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,88000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,74300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,74300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,74300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.99
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2020.0,Q1,2020-01-01,2020-03-31,2020-04-24 16:04:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
